Fool.com
Growing the love for stocks
Results 11 - 20 of 607 : Previous 1 2 3 4 5 6 7 8 9 Next
4 Platform Drugmakers to Invest In
No special shoes required.
It won't be a tough decision for patients to make.
Bristol-Myers to Mead Johnson: It's time to walk on your own.
A Big Upgrade for Sanofi-Aventis
This bullish call comes from more than just one analyst.
4-Star Stocks Poised to Pop: Alkermes
Market-trouncing returns could be written in these stars.
Music to Health-Care Investors' Ears
Are faster FDA review times coming?
Abbott Puts a Nail in Merck's Coffin
There's a clear winner from the American Heart Association conference.
The company makes a deal that could pay off big, but could flame out instead.
One Investment to Avoid in Today's Market
When good theories go terribly wrong.
Drug Companies Should Think Smaller
Sanofi-aventis looks to break R&D into smaller chunks.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK